Government has reaffirmed its commitment to integrating natural health solutions into national healthcare delivery under MahamaCare, but only when backed by rigorous scientific evidence and regulatory approval.
The Deputy Minister for Health, Grace Ayensu-Danquah, stressed that safety and credibility will remain non-negotiable in the adoption of natural products for chronic disease management.
Speaking on her behalf at the Natural Health & Wellness Expo 2026, Director for Traditional and Alternative Medicine, Dr. Anastasia Yirenkyi, emphasized that natural health products must undergo thorough scientific evaluation, proper standardization, and production under Good Manufacturing Practices before they can be integrated into mainstream healthcare.
She added that such products must also be supported by reliable safety data and receive approval from the Food and Drugs Authority (FDA).
According to the Deputy Minister, MahamaCare offers a strong platform for collaboration between government, researchers, innovators, and manufacturers to develop evidence-based solutions that address the rising burden of chronic diseases in Ghana.
However, she made it clear that only products that meet established scientific and regulatory standards will receive government endorsement, a move aimed at protecting public health while strengthening confidence in Ghana’s growing natural health industry.
The initiative signals a forward-looking approach to healthcare delivery, blending innovation with strict regulatory oversight to ensure safe and effective treatment options for Ghanaians.
